New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 8, 2014
05:59 EDTTWC, ARIAStocks with implied volatility below IV index mean; TWC ARIA
Stocks with implied volatility movement; Time Warner Cable (TWC) 24, ARIAD (ARIA) 107 according to iVolatility.
News For TWC;ARIA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
March 27, 2015
06:14 EDTTWCAT&T betting on slow decline in traditional cable packages, WSJ says
AT&T (T) knew that demand for cable bundles had likely peaked when it bought DirecTV (DTV), but the company believes the decline in traditional cable businesses will be slower than anticipated, allowing it to fund upgrades to its broadband network, reports the Wall Street Journal, citing statements by Chief Strategy Officer John Stankey. "The world is going to be broadband... and that is where we want to be," said Stankey. The Journal notes that Apple (AAPL), Time Warner's (TWC) HBO, and Dish (DISH) have launched or plan to launch web-TV packages and services. Reference Link
March 26, 2015
08:08 EDTTWCTime Warner Cable standalone value $172 per share, says Wunderlich
Subscribe for More Information
March 25, 2015
15:33 EDTTWCCPUC vote on Comcast deal pushed out to May 7, LA Times reports
Subscribe for More Information
10:29 EDTTWCDISH Chairman Ergen says Comcast, TWC merger should be blocked
Subscribe for More Information
09:29 EDTARIAARIAD reports dismissal of class action suit in federal district court
ARIAD Pharmaceuticals announced that the United States District Court for the District of Massachusetts dismissed the shareholder class action lawsuit filed in late 2013 against the company and certain of its officers, directors and underwriters in connection with the events leading up to the temporary suspension of the marketing and commercial distribution of Iclusig on October 31, 2013, and subsequent re-launch in January 2014 based on revised U.S. prescribing information and a risk evaluation and mitigation strategy. The suit alleged that certain of the company defendants made a series of false and misleading statements regarding the safety, efficacy and commercial prospects of Iclusig. The Court granted the company’s motion to dismiss the lawsuit, concluding that the plaintiffs failed to establish that any such statements violated the company’s disclosure obligations as asserted in the complaint. “We are pleased that for the second time in as many weeks, the Court has granted our motion to dismiss what we believed from the outset was another meritless lawsuit,” said Harvey J. Berger, M.D., chairman and CEO. “Our corporate values of integrity and mutual respect are always at the forefront as we continue to focus on executing our plan for sustained revenue growth and operational excellence, leading to anticipated profitability in 2018.”
09:22 EDTTWCTime Warner Cable disputes report of Dodgers channel writedown, LA Times says
Subscribe for More Information
March 24, 2015
09:22 EDTARIAOn The Fly: Pre-market Movers
Subscribe for More Information
08:19 EDTTWCTime Warner Cable expected to write down Dodgers deal by up to $1B, NY Post says
Time Warner Cable (TWC) is expected to write down the value of its LA Dodgers distribution rights by up to $1B, reports the New York Post, citing sources. The writedown may be a requirement before any deal with Comcast (CMCSA, CMCSK) can be made, suggested one of the sources. Reference Link
07:37 EDTARIAARIAD announces approval of Iclusig in Israel
ARIAD Pharmaceuticals and Medison Pharma announced that the Israeli Ministry of Health has granted regulatory approval for Iclusig, ponatinib, in Israel for adult patients with: Chronic phase, accelerated phase, or blast phase chronic myeloid leukaemia who are resistant to dasatinib or nilotinib, who are intolerant to dasatinib or nilotinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation Philadelphia chromosome-positive acute lymphoblastic leukaemia who are resistant to dasatinib, who are intolerant to dasatinib and for whom subsequent treatment with imatinib is not clinically appropriate, or who have the T315I mutation. ARIAD submitted its application for Iclusig to the Israeli Ministry of Health in June 2014. Commercial launch of Iclusig is expected to occur in Q2.
March 20, 2015
09:59 EDTTWCCharter may have interest in Cablevision 'at some point,' says Detwiler
Detwiler Fenton believes there is truth to last week's reports of Charter (CHTR) being in talks to acquire Bright House Networks. In addition, the firm says its checks indicate Charter may have interest in buying Suddenlink Communications and Cablevision (CVC) "at some point" as a part of a lager acquisition strategy. Detwiler adds Charter's potential deal strategy assumes Comcast's (CMCSA) bid for Time Warner (TWC) wins regulatory approval. Should the deal not get approved, Detwiler believes Charter will turn its attention back to Time Warner.
March 18, 2015
07:30 EDTTWCAT&T-DirecTV getting less attention than Comcast-Time Warner Cable, Reuters says
Subscribe for More Information
March 16, 2015
13:22 EDTTWCThe Children's Investment Fund reports 5.0% passive stake in Time Warner Cable

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use